Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2012 Aug 15;2012(8):CD006742.
doi: 10.1002/14651858.CD006742.pub2.

Pharmacotherapy for mild hypertension

Diana Diao  1 , James M Wright, David K Cundiff, Francois Gueyffier
Affiliations
Meta-Analysis

Pharmacotherapy for mild hypertension

Diana Diao et al. Cochrane Database Syst Rev. .

Abstract

Background: People with no previous cardiovascular events or cardiovascular disease represent a primary prevention population. The benefits and harms of treating mild hypertension in primary prevention patients are not known at present. This review examines the existing randomised controlled trial (RCT) evidence.

Primary objective: To quantify the effects of antihypertensive drug therapy on mortality and morbidity in adults with mild hypertension (systolic blood pressure (BP) 140-159 mmHg and/or diastolic BP 90-99 mmHg) and without cardiovascular disease.

Search methods: We searched CENTRAL (2011, Issue 1), MEDLINE (1948 to May 2011), EMBASE (1980 to May 2011) and reference lists of articles. The Cochrane Database of Systematic Reviews and the Database of Abstracts of Reviews of Effectiveness (DARE) were searched for previous reviews and meta-analyses of anti-hypertensive drug treatment compared to placebo or no treatment trials up until the end of 2011.

Selection criteria: RCTs of at least 1 year duration.

Data collection and analysis: The outcomes assessed were mortality, stroke, coronary heart disease (CHD), total cardiovascular events (CVS), and withdrawals due to adverse effects.

Main results: Of 11 RCTs identified 4 were included in this review, with 8,912 participants. Treatment for 4 to 5 years with antihypertensive drugs as compared to placebo did not reduce total mortality (RR 0.85, 95% CI 0.63, 1.15). In 7,080 participants treatment with antihypertensive drugs as compared to placebo did not reduce coronary heart disease (RR 1.12, 95% CI 0.80, 1.57), stroke (RR 0.51, 95% CI 0.24, 1.08), or total cardiovascular events (RR 0.97, 95% CI 0.72, 1.32). Withdrawals due to adverse effects were increased by drug therapy (RR 4.80, 95%CI 4.14, 5.57), ARR 9%.

Authors' conclusions: Antihypertensive drugs used in the treatment of adults (primary prevention) with mild hypertension (systolic BP 140-159 mmHg and/or diastolic BP 90-99 mmHg) have not been shown to reduce mortality or morbidity in RCTs. Treatment caused 9% of patients to discontinue treatment due to adverse effects. More RCTs are needed in this prevalent population to know whether the benefits of treatment exceed the harms.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1
1
Study flow diagram.
2
2
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
1.1
1.1. Analysis
Comparison 1 Treatment versus No Treatment, Outcome 1 Mortality.
1.2
1.2. Analysis
Comparison 1 Treatment versus No Treatment, Outcome 2 Stroke.
1.3
1.3. Analysis
Comparison 1 Treatment versus No Treatment, Outcome 3 Coronary Heart Disease.
1.4
1.4. Analysis
Comparison 1 Treatment versus No Treatment, Outcome 4 Total CV events.
1.5
1.5. Analysis
Comparison 1 Treatment versus No Treatment, Outcome 5 Withdrawals due to adverse effects.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

ANBP {published data only}
    1. A report by the Management Committee of the Australian Theraputic Trial in Mild Hypertension. Untreated mild hypertension. Lancet 1982;1(8265):185‐91. - PubMed
    1. Abernethy JD. The Australian Therapeutic Trial in Mild Hypertension. Hypertension 1984;6(5):774‐6 1984;6(5):774‐776. - PubMed
    1. Abernethy JD. The need to treat mild hypertension. Misinterpretation of results from the Australian trial. JAMA 1986;256(22):3134‐37. - PubMed
    1. Anonymous. The Australian Therapeutic Trial in Mild Hypertension. Report by the management committee. Lancet 1980;1:1261‐1267. - PubMed
    1. Doyle AE. Cardiovascular morbidity and mortality in mild hypertension: The Australian Trial. Journal of Cardiovascular Pharmacology 1985;7(Suppl 2):S10‐13. - PubMed
MRC {published data only}
    1. Anonymous. Adverse reactions to bendrofluazide and propanolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension. Lancet 1981;2(8246):539‐43. - PubMed
    1. Anonymous. Coronary heart disease in Medical Research Council trial of mild hypertension. Medical Research Council Working Party on Mild Hypertension. British Heart Journal 1988;59(3):364‐378. - PMC - PubMed
    1. Anonymous. Course of blood pressure in mild hypertension after withdrawal of long term antihypertensive treatment. Medical Research Council Working Party on Mild Hypertension. Brit Med J 1986;293(6553):988‐92. - PMC - PubMed
    1. Anonymous. Randomised controlled trial of treatment of mild hypertension: design and pilot trial. Report of the Medical Research Council Working party on mild to Moderate Hypertension. Brit Med J 1977;1(6074):1437‐40. - PMC - PubMed
    1. Anonymous. Stroke and coronary heart disease in mild hypertension: risk factors and the value of treatment. Medical Research Council Working Party on Mild Hypertension. Brit Med J 1988;296(6636):1565‐70. - PMC - PubMed
SHEP {published data only}
    1. Applegate WB. Davis BR. Black HR, et al. Prevalence of postural hypotension at baseline in the systolic hypertension in the elderly program (SHEP) cohort. Journal of American Geriatric Society 1991;39:1057‐64. - PubMed
    1. Bearden D. Allman R. McDonald R, et al. Age, race, and gender variation in the utilization of coronary artery bypass surgery and angioplasty in SHEP. Journal of the American Geriatric Society 1994;42:1143‐49. - PubMed
    1. Black HR. Unger D. Burlando A, et al. Part 6: Baseline physical examination findings.. Hypertension 1991;17(3 (Suppl II)):II‐77‐II‐101. 1991;17(Suppl II):77‐101. - PubMed
    1. Borhani NO. Applegate WB. Cutler JA, et al. Part 1: rationale and design. Hypertension 1991;17(Suppl II):2‐15. - PubMed
    1. Brittain E. Palensky J. Blood J and Wittes J. Blinded subjective rankings as a method of assessing treatment effect: a large sample example from the systolic hypertension in the elderly program (SHEP). Statistics in Medicine 1997;16:681‐93. - PubMed
VA‐NHLBI {published data only}
    1. Perry HM Jr, Goldman AI, Lavin MA, Schnaper HW, Fitz AE, et al. Evaluation of drug treatment in mild hypertension: VA‐NHLBI feasibility trial. Plan and preliminary results of a two‐year feasibility trial for a multicenter intervention study to evaluate the benefits versus the disadvantages of treating mild hypertension. Ann N Y Acad Sci 1978;304:267‐92. [PUBMED: 360921] - PubMed
    1. Perry Jr HM, et al. Treatment of mild hypertension. Preliminary results of a two year feasibility trial. Circ Res 1977;40(suppl):1180‐87. - PubMed

References to studies excluded from this review

COOPE {published data only}
    1. Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. BMJ 1986;293:1145‐51. - PMC - PubMed
FEVER 2005 {published data only}
    1. Liu L, Zhang Y, Liu G, Li W, Zhang X, Zanchetti A. The Felodipine Event Reduction (FEVER) Study: a randomized long‐term placebo‐controlled trial in Chinese hypertensive patients. Journal of Hypertension 2005;23:2157‐2172. - PubMed
HDFP {published data only}
    1. HDFP. Effect of stepped care treatment on the incidence of myocardial infarction and angina pectoris. 5‐year findings of the hypertension detection and follow‐up program. Hypertension 1984;6(Suppl 1):198‐206. - PubMed
    1. HDFP. Five‐year findings of the hypertension detection and follow‐up program III. Reduction in stroke incidence among persons with high blood pressure. JAMA 1982;247:633‐638. - PubMed
    1. HDFP. The effect of treatment on mortality in “mild”hypertension Results of the hypertension detection and follow‐up program. N Engl J Med 1982;307:976‐980. - PubMed
    1. Hypertension Detection and Follow‐up Program Cooperative Group. Five‐year findings of the Hypertension Detection and Follow‐up Program: I.Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979;242:2562‐71. - PubMed
    1. Hypertension Detection and Follow‐up Program Cooperative Group (HDFP). Five‐year findings of the hypertension detection and follow‐up program II Mortality by race‐sex and age. JAMA 1979;247:2572‐2576.. - PubMed
MRC2 {published data only}
    1. Medical Research Council Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992;304:405‐12. - PMC - PubMed
MRFIT {published data only}
    1. Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial. Risk factor changes and mortality results. JAMA 1982 Sep 24;248(12):1465‐77. - PubMed
Oslo {published data only}
    1. Helgeland A. Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. Am J Med 1980 Nov;69(5):725‐32. [PUBMED: 7001898] - PubMed
    1. Helgeland A, Leren P. Oslo study: Treatment of mild hypertension. Nephron 1987;47(Suppl 1):108‐110. - PubMed
    1. Helgeland A. Baksaas IA, Leren P. Mild hypertension ‐ early drug treatment or follow‐up only? the Oslo study. Acta Medica Scandinavica. Supplementum 1979;626:34‐36. - PubMed
    1. Helgeland A. Hjermann I. Holme I, Liren P. Serum triglycerides and serum uric acid in untreated and thiazide‐treated patients with mild hypertension. The American Journal of Medicine 1978;64:34‐38. - PubMed
    1. Helgeland A. Leren P. Foss OP, et al. Serum glucose levels during long‐term observation of treated and untreated men with mild hypertension. The American Journal of Medicine 1984;76:802‐805. - PubMed
USPHSHC {published data only}
    1. Smith WM. Treatment of mild hypertension: results of a ten‐year intervention trial. Circ Res 1977 May;40(5 Suppl 1):I98‐105. [PUBMED: 140029] - PubMed

Additional references

Collins 1990
    1. Collins R, Peto R, Macmahon S, Hebert P, et al. Blood pressure, stroke, and coronary heart disease‐ Part 2, Short‐term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827‐838. - PubMed
Gueyffier 1996
    1. Gueyffier F, Froment A, Gouton M. New meta‐analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit. J Human Hyperten 1996;10:1‐8. - PubMed
Mancia 2009
    1. Mancia G, Laurent S, Agabiti‐Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Journal of Hypertension 2009;27:1‐38. - PubMed
Marchant 2011
    1. Marchant I, Nony P, Cucherat M, Boissel J‐P, Thomas SR, et al. The Global Risk Approach Should Be Better Applied in French Hypertensive Patients: A Comparison between Simulation and Observation Studies. PLoS ONE 2011;6(3):e17508. [e17508. doi:10.1371/journal.pone.0017508] - PMC - PubMed
Psaty 1997
    1. Psaty BM, Smith NL, Siscovick DS, Koepsell TD, et al. Health outcomes associated with antihypertensive therapies used as first‐ line agents. A systematic review and meta‐analysis. JAMA 1997;277:739‐745. - PubMed
Psaty 2003
    1. Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS. Health outcomes associated with various antihypertensive therapies used as first‐line agents: a network meta‐analysis. JAMA 2003;289(19):2534‐2544. - PubMed
Quan 2000
    1. Quan A, Kerlikowske K, Gueyffier F, Boissel JP, for the INDANA Investigators. Pharmacotherapy for hypertension in women of different races. Cochrane Database of Systematic Reviews 2000, Issue 3. [DOI: 10.1002/14651858.CD002146] - DOI - PubMed
Therapeutics Initiative 2007
    1. Therapeutics Intitiative. Mild Hypertension‐ An approach to using evidence in the decision making process. Therapeutics Letter Jan‐Feb 2007;62:1‐2. - PubMed
Wright 1999
    1. Wright JM. Cheng‐Han Lee, Chambers KC. Systematic review of antihypertensive therapies: does the evidence assist in choosing a first‐line drug?. CMAJ 1999;161:25‐32. - PMC - PubMed
Wright 2009
    1. Wright JM, Musini VM. First‐line drugs for hypertension. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD001841] - DOI - PubMed

Publication types

MeSH terms

Substances